112 related articles for article (PubMed ID: 146056)
1. Topical bioavailability of a potential anti-acne agent (SC-23110) as determined by cumulative excretion and areas under plasma concentration time curves.
Wester RC; Noonan PK
J Invest Dermatol; 1978 Feb; 70(2):92-4. PubMed ID: 146056
[TBL] [Abstract][Full Text] [Related]
2. In vivo percutaneous absorption of acetochlor in the rhesus monkey: dose-response and exposure risk assessment.
Wester RC; Melendres JL; Maibach HI
Food Chem Toxicol; 1996 Oct; 34(10):979-83. PubMed ID: 9012773
[TBL] [Abstract][Full Text] [Related]
3. Relationship of topical dose and percutaneous absorption in rhesus monkey and man.
Wester RC; Maibach HI
J Invest Dermatol; 1976 Oct; 67(4):518-20. PubMed ID: 823268
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
Wester RC; Noonan PK; Smeach S; Kosobud L
J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous absorption and excretion of alachlor in rhesus monkeys.
Kronenberg JM; Fuhremann TW; Johnson DE
Fundam Appl Toxicol; 1988 May; 10(4):664-71. PubMed ID: 3396793
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous absorption and excretion of xenobiotics after topical and intravenous administration to pigs.
Carver MP; Riviere JE
Fundam Appl Toxicol; 1989 Nov; 13(4):714-22. PubMed ID: 2620792
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous absorption of testosterone in the newborn rhesus monkey: comparison to the adult.
Wester RC; Noonan PK; Cole MP; Maibach HI
Pediatr Res; 1977 Jun; 11(6):737-9. PubMed ID: 405649
[TBL] [Abstract][Full Text] [Related]
8. Species differences in the metabolism and disposition of spironolactone.
Karim A; Kook C; Zitzewitz DJ; Zagarella J; Doherty M; Campion J
Drug Metab Dispos; 1976; 4(6):547-55. PubMed ID: 11976
[TBL] [Abstract][Full Text] [Related]
9. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD
Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265
[TBL] [Abstract][Full Text] [Related]
11. Influence of the size of the area of treatment on percutaneous absorption of estradiol in the rat.
Chanez JF; de Lignières B; Marty JP; Wepierre J
Skin Pharmacol; 1989; 2(1):15-21. PubMed ID: 2627411
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris.
Thiboutot DM; Willmer J; Sharata H; Halder R; Garrett S
Clin Pharmacokinet; 2007; 46(8):697-712. PubMed ID: 17655376
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
Tang-Liu DD; Matsumoto RM; Usansky JI
Clin Pharmacokinet; 1999 Oct; 37(4):273-87. PubMed ID: 10554045
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro percutaneous absorption of [14C]pyrene in Sprague Dawley male rats: skin reservoir effect and consequence on urinary 1-OH pyrene excretion.
Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Ferrari E
Arch Toxicol; 2008 Oct; 82(10):739-47. PubMed ID: 18421439
[TBL] [Abstract][Full Text] [Related]
15. In vivo percutaneous absorption of hydrocortisone: multiple-application dosing in man.
Melendres JL; Bucks DA; Camel E; Wester RC; Maibach HI
Pharm Res; 1992 Sep; 9(9):1164-7. PubMed ID: 1409398
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin.
Davis DA; Kraus AL; Thompson GA; Olerich M; Odio MR
J Pharm Sci; 1997 Aug; 86(8):896-9. PubMed ID: 9269866
[TBL] [Abstract][Full Text] [Related]
17. Effects of anatomical site and occlusion on the percutaneous absorption and residue pattern of 2,6-[ring-14C]parathion in vivo in pigs.
Qiao GL; Chang SK; Riviere JE
Toxicol Appl Pharmacol; 1993 Sep; 122(1):131-8. PubMed ID: 8378927
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo percutaneous absorption of 14C-octamethylcyclotetrasiloxane (14C-D4) and 14C-decamethylcyclopentasiloxane (14C-D5).
Jovanovic ML; McMahon JM; McNett DA; Tobin JM; Plotzke KP
Regul Toxicol Pharmacol; 2008 Mar; 50(2):239-48. PubMed ID: 18178298
[TBL] [Abstract][Full Text] [Related]
19. Glyphosate skin binding, absorption, residual tissue distribution, and skin decontamination.
Wester RC; Melendres J; Sarason R; McMaster J; Maibach HI
Fundam Appl Toxicol; 1991 May; 16(4):725-32. PubMed ID: 1884912
[TBL] [Abstract][Full Text] [Related]
20. Topical and systemic absorption of sodium pyrithione following topical application to the nails of the rhesus monkey.
Mayer PR; Couch RC; Erickson MK; Wooldridge CB; Brazzell RK
Skin Pharmacol; 1992; 5(3):154-9. PubMed ID: 1445705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
